Skip to main content

anti-tmprss6 monoclonal antibody disc-3405

Generic: Anti-TMPRSS6 Monoclonal Antibody DISC-3405

anti-tmprss6 monoclonal antibody disc-3405: 2 clinical trials tracked.

anti-tmprss6 monoclonal antibody disc-3405 evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about anti-tmprss6 monoclonal antibody disc-3405, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Sickle Cell Disease
Clinical Trial Registry Records (2)

A Phase 1b Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-3405 in Participants With Sickle Cell Disease

NCT07187973Registry updated 2026-10-05·Phase 1·IRON
Recruiting

Primary endpoint: Safety and tolerability of DISC-3405 administration in participants with SCD

Interventionalopen24 targetStarted 2026-01Completion 2027-1011 sites · United StatesDisc Medicine, Inc

A Phase 2, Open-Label Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DISC-3405 in Participants With Polycythemia Vera (PV)

NCT06985147Registry updated 2026-07-31·Phase 2·IRON
Active, not recruiting

Primary endpoint: Number of participants with treatment-related adverse events as assessed by CTCAE

Interventionalopen60 targetStarted 2025-08Completion 2029-0215 sites · United StatesDisc Medicine, Inc